Quantcast

Latest FDA Stories

2014-07-16 20:23:36

Animal Deaths Emerging Nationwide due to Illegal Compounded Drugs WASHINGTON, July 16, 2014 /PRNewswire-USNewswire/ -- Today, the Animal Health Institute, along with the experts in the field of animal health and veterinary medicine brought together consumers, media, veterinary experts, policymakers and industry stakeholders for a teleconference and two Congressional briefings calling for greater action by the U.S. Food and Drug Administration (FDA) on illegal animal drug...

2014-07-16 12:28:07

For U.S. Media Only RIDGEFIELD, Conn., July 16, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF). The efficacy and safety of nintedanib in the treatment of IPF has not been established. "Boehringer Ingelheim is proud that...

2014-07-16 12:27:49

BETHESDA, Md., July 16, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) has confirmed FDA's Stephen Ostroff, M.D., Acting Chief Scientist in the Office of the Commissioner will present "FDA's Views on Scientific Advances and their Impact on Manufacturing of the Future" on September 8, 2014 in at the opening plenary session of the 2014 PDA/FDA Joint Regulatory Conference in Washington, DC at the Renaissance Hotel. The Conference dates are September 8-10, 2014,...

2014-07-16 12:27:48

LOUVAIN-LA-NEUVE, Belgium, July 16, 2014 /PRNewswire/ -- IBA (Ion Beam Applications SA [http://group.iba-worldwide.com/iba-solutions ]), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has received Marketing Authorization from the U.S. Food and Drug Administration (FDA) for its Compact Gantry Beam Line (CGBL: FDA 510(k) K132919). IBA anticipates that this regulatory approval will intensify the international interest in...

2014-07-16 12:27:35

Now the Freedom® portable driver is available to all clinically stable SynCardia Total Artificial Heart patients in the US so they can be discharged from the hospital to enjoy life with family while waiting for their donor hearts. TUCSON, Ariz., July 16, 2014 /PRNewswire/ -- The Freedom® portable driver received FDA approval on June 26, 2014 for use with the SynCardia temporary Total Artificial Heart as a bridge to transplantation in cardiac transplant candidates who are clinically...

2014-07-16 08:29:39

CASTLE ROCK, Colo., July 16, 2014 /PRNewswire/-- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid, multi-analyte assay for aiding in identifying children, adolescent and young adult patients that are at low risk for appendicitis, updated on recent activities concerning its U. S. Food and Drug Administration (FDA) submission for the APPY1 Test that was filed in March 2014. The...

2014-07-15 23:11:01

On July 11, the FDA alerted healthcare professionals not to use drugs marketed as sterile produced by Unique Pharmaceuticals Ltd. as they may be contaminated. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) July 15, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Sterile Drug Products. The FDA notified...

2014-07-15 23:01:36

The Device Software Verification and Validation On-Demand Webinar will give attendees a clear understanding of FDA inspector expectations and how to meet them, with a specific focus on software that is as-product, in-product, process and/or in overall manufacturing and operations. Why risk FDA sanctions, let alone multimillion-dollar liability lawsuits? Falls Church, VA (PRWEB) July 15, 2014 Device Software Verification and Validation: Get Ready for a New Breed of Investigators...

2014-07-15 08:29:23

This Pelvic Muscle Exercise Program Strengthens the Muscles Controlling the Penis CHEVY CHASE, Md., July 15, 2014 /PRNewswire/ -- The Private Gym, LLC announced today the release of its groundbreaking, innovative fitness program, Private Gym, the first FDA registered exercise program that strengthens the pelvic muscles. Using the Private Gym program, in less than 10 minutes a day, three days a week, men can strengthen the muscles that support and control the penis. Pelvic muscle...

2014-07-15 08:28:22

KEYSVILLE, Va., July 15, 2014 /PRNewswire/ -- S&M Brands, Inc., one of Virginia's largest privately held growers, manufacturers and distributors of premium quality tobacco products, announced today that it has received Substantial Equivalent orders from the FDA on its newly redesigned Riverside(® )Cigarette brand. A significant factor in this announcement is that S&M Brands, Inc. is one of the few companies, behind Lorillard, Inc., that has navigated the Tobacco Control Act...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related